About Miltel
Miltel is a company based in Hiroshima (Japan) founded in 2012 by Eitoshi Tahara. Miltel has raised $5.28 million across 3 funding rounds from investors including Kyocera, Beyond Next Ventures and Medical Net. Miltel operates in a competitive market with competitors including Lily MedTech, Cranebio and MyCode, among others.
- Headquarter Hiroshima, Japan
- Founders Eitoshi Tahara
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$5.28 M (USD)
in 3 rounds
-
Latest Funding Round
Not available
-
Investors
Kyocera
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Miltel
Miltel has successfully raised a total of $5.28M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Miltel
Miltel has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Kyocera, Beyond Next Ventures and Medical Net.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Deep-tech investments and incubation services are provided for researchers and entrepreneurs addressing global challenges.
|
Locked | Locked | Locked | |
|
Hiroshima Venture Capital is engaged in venture and private equity investments.
|
Locked | Locked | Locked | |
|
NTT Group backed venture capital fund
|
Locked | Locked | Locked |
Investor details for Miltel
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Miltel
Investment portfolio details for Miltel
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Miltel
Detailed financials for Miltel
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Miltel Comparisons
Peer comparison for Miltel
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Miltel
Miltel operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Lily MedTech, Cranebio and MyCode, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Ultrasound-based diagnostic imaging for breast cancer detection is developed.
|
|
| Locked | Locked | Locked |
Self-service genetic test kits for women's health are developed.
|
|
| Locked | Locked | Locked |
Provides reliable genetic testing services for personalized health insights.
|
Detailed competitors of Miltel
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Miltel
Complete news archive for Miltel
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Miltel
Miltel was founded in 2012 and raised its 1st funding round 3 years after it was founded.
Miltel is headquartered in Hiroshima, Japan.
Miltel is a funded company, having raised a total of $5.28M across 3 funding rounds to date.
Miltel was founded in 2012 in Hiroshima, Japan, and operates in the biotechnology sector focused on aging diagnostics. Telomere testing services are offered to measure gene strength and fatigue resulting from daily stress. These assessments assist in evaluating cellular senescence. The companys domain is mirtel.co.jp, with Eitoshi Tahara serving as founder.
Miltel's top competitors include Lily MedTech, Cranebio and MyCode.
Miltel has 5 investors. Key investors include Kyocera, Beyond Next Ventures, Medical Net, Hiroshima Venture Capital, and Ntt Docomo Ventures.